GW Pharma (GWPH) Reports Q4 Loss of $0.23/Share

GW Pharma (NASDAQ: GWPH) reported Q4 EPS of ($0.23), versus ($0.18) reported last year. Revenue for the quarter came in at $2.34 million, versus $2.37 million reported last year.

For earnings history and earnings-related data on GW Pharma (GWPH) click here.

You May Also Be Interested In

• Rivian reports record Q3 deliveries, beats estimates, shares rise
• Onto Innovation gains on bullish RBC initiation citing advanced packaging growth
• Reaction roundup: Experts, analysts weigh in on September jobs report